Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Bibliographic Details
Main Authors:	Fan, Q. (Author), Huang, J. (Author), Kou, X. (Author), Li, N. (Author), Li, Y. (Author), Liang, X. (Author), Liu, Y. (Author), Wang, Y. (Author), Xu, B. (Author), Yin, X. (Author), Zhang, J. (Author), Zhang, S. (Author), Zhong, H. (Author), Zhuang, Z. (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Online Access:	View Fulltext in Publisher

Similar Items

Cardiotoxicity and Mechanisms of Immune Checkpoint Inhibitors
by: DONG Shuang, et al.
Published: (2018-11-01)

Cardiotoxicity from immune checkpoint inhibitors
by: Lars Michel, et al.
Published: (2019-12-01)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)

Managing cardiotoxicity associated with immune checkpoint inhibitors
by: Sireesha Upadhrasta, et al.
Published: (2019-03-01)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
by: Qi J, et al.
Published: (2021-02-01)

Investigation of Potential Cardiotoxicity of Anti-PD-1 Immune Checkpoint Inhibitor
by: Woan Ting,Tay, et al.
Published: (2019)

Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies
by: Shirley Xu, et al.
Published: (2021-02-01)

An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors
by: Roberta Esposito, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019-11-01)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
by: Lin X, et al.
Published: (2021-03-01)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
by: Li GZ, et al.
Published: (2019-11-01)

Cancer immunotherapy beyond immune checkpoint inhibitors
by: Julian A. Marin-Acevedo, et al.
Published: (2018-01-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
by: YU Lin, et al.
Published: (2021-08-01)

Gender differences in cardiotoxicities associated with immune checkpoint inhibitor therapy in cancer patients
by: Sheharyar Minhas, et al.
Published: (2020-01-01)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients
by: Mandar A. Aras, MD, PhD, et al.
Published: (2020-09-01)

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
by: Bai X, et al.
Published: (2019-11-01)

Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
by: Anita Mazloom, et al.
Published: (2020-08-01)

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
by: Melissa Y.Y. Moey, MD, MSc, et al.
Published: (2020-09-01)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020-08-01)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Hui Qiu, et al.
Published: (2021-09-01)

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
by: Marta Rocha, et al.
Published: (2018-12-01)

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
by: Wei Xiong, et al.
Published: (2021-08-01)

Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
by: Hiromichi Nakajima, et al.
Published: (2021-01-01)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
by: Zheng-Hang Wang, et al.
Published: (2018-03-01)

Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
by: Angela Y Higgins, et al.
Published: (2021-01-01)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
by: Chenxin Chen, et al.
Published: (2021-02-01)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
by: Valentina Tateo, et al.
Published: (2020-11-01)

Immune checkpoint inhibitors: An innovation in immunotherapy for the treatment and management of patients with cancer
by: Jennifer Dine, et al.
Published: (2017-01-01)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
by: Hao-Chien Hung, et al.
Published: (2021-03-01)

The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
by: Li P, et al.
Published: (2018-10-01)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
by: Liu W, et al.
Published: (2020-07-01)

Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Jiang Y, et al.
Published: (2019-02-01)

New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors
by: YANG Changliang, et al.
Published: (2018-12-01)

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy with Immune Checkpoint Inhibitors
by: Eugénia Matos Pires, et al.
Published: (2018-04-01)

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials
by: Li J, et al.
Published: (2019-02-01)

Advance in Drug Resistance Mechanism of Immune Checkpoint Inhibitors
by: ZHANG Lanlan, et al.
Published: (2020-08-01)

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
by: Uday N. Shivaji, et al.
Published: (2019-11-01)

The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
by: Anastasia Mpakali, et al.
Published: (2021-01-01)

Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications
by: Pierre Decazes, et al.
Published: (2020-02-01)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01)